Department of Physiology, Institute of Biomedicine, Biomedicum Helsinki, University of Helsinki, FI-00014 Helsinki, Finland and Department of Cellular and Molecular Medicine, Molecular Endocrinology Laboratory, Katholieke Universiteit Leuven, Campus Gasthuisberg, BE-3000 Leuven, Belgium.
Nucleic Acids Res. 2014 Apr;42(7):4230-40. doi: 10.1093/nar/gkt1401. Epub 2014 Jan 22.
The DNA-binding domains (DBDs) of class I steroid receptors-androgen, glucocorticoid, progesterone and mineralocorticoid receptors-recognize a similar cis-element, an inverted repeat of 5'-AGAACA-3' with a 3-nt spacer. However, these receptors regulate transcription programs that are largely receptor-specific. To address the role of the DBD in and of itself in ensuring specificity of androgen receptor (AR) binding to chromatin in vivo, we used SPARKI knock-in mice whose AR DBD has the second zinc finger replaced by that of the glucocorticoid receptor. Comparison of AR-binding events in epididymides and prostates of wild-type (wt) and SPARKI mice revealed that AR achieves selective chromatin binding through a less stringent sequence requirement for the 3'-hexamer. In particular, a T at position 12 in the second hexamer is dispensable for wt AR but mandatory for SPARKI AR binding, and only a G at position 11 is highly conserved among wt AR-preferred response elements. Genome-wide AR-binding events agree with the respective transcriptome profiles, in that attenuated AR binding in SPARKI mouse epididymis correlates with blunted androgen response in vivo. Collectively, AR-selective actions in vivo rely on relaxed rather than increased stringency of cis-elements on chromatin. These elements are, in turn, poorly recognized by other class I steroid receptors.
I 类甾体受体(雄激素受体、糖皮质激素受体、孕激素受体和盐皮质激素受体)的 DNA 结合域(DBD)识别相似的顺式元件,即 5'-AGAACA-3'的反向重复,间隔 3 个核苷酸。然而,这些受体调节的转录程序在很大程度上是受体特异性的。为了研究 DBD 本身在确保雄激素受体(AR)在体内与染色质结合的特异性中的作用,我们使用了 SPARKI 敲入小鼠,其 AR DBD 的第二个锌指被糖皮质激素受体的锌指取代。比较野生型(wt)和 SPARKI 小鼠附睾和前列腺中的 AR 结合事件,发现 AR 通过对 3'-六聚体的序列要求较不严格来实现选择性染色质结合。特别是,第二个六聚体中第 12 位的 T 对 wt AR 是可有可无的,但对 SPARKI AR 结合是必需的,而只有第 11 位的 G 在 wt AR 优先反应元件中高度保守。全基因组 AR 结合事件与各自的转录组谱一致,即 SPARKI 小鼠附睾中 AR 结合的减弱与体内雄激素反应的减弱相关。总之,体内 AR 的选择性作用依赖于染色质上顺式元件的宽松而非严格性。这些元件反过来又被其他 I 类甾体受体识别不良。